Clinical trial
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile…
NCT00379756 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00379756 |
|---|---|
| Title | A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia |
| Official title | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Erectile Dysfunction |
| Intervention type | Drug |
| Interventions | LEVITRA (vardenafil), placebo |
| Enrollment | 395 |
| Start date | May 22, 2006 |
| Primary completion | May 17, 2007 |
| Completion | May 17, 2007 |
| First posted | Sep 22, 2006 |
| Last update posted | Aug 16, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: